<DOC>
	<DOCNO>NCT00919399</DOCNO>
	<brief_summary>This Phase II non-randomized , open , uncontrolled bi-centric study hormonal induction exemestane ( Aromasin ) + tamoxifen evaluate effectiveness exemestane ( Aromasin ) tamoxifen rate clinical response menopausal patient tumor locally advance breast . Hormone therapy administer dose 25mg/day exemestane 20 mg / day 4 month tamoxifen .</brief_summary>
	<brief_title>Exemestane ( Aromasine ) + Tamoxifen - Breast Neo-Adjuvant</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Exemestane</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>Breast cancer histologically proven 14 G 16 G microbiopsy confirmation diagnosis , evaluation histology prognosis grade , hormone receptor obtain sample study biological factor . Menopausal patient define follow : Natural menopause &gt; = 1 year , Surgical ovariectomy . T unilateral tumor &gt; 3 cm , N 12 , M0 M + , noninflammatory . Hormone receptor positive . RE positive PR positive histochemical technique ( + 10 % cell express receptor ) No previous treatment disease chemotherapy , hormone therapy , surgery radiotherapy . Discontinuation replacement therapy menopause least 1 month Age &gt; = 60 year Evaluable disease Performance Status &lt; = 2 Biological function use follow criterion : neutrophil &gt; = 2.10E9 / l , Platelets &gt; = 100.10E9 / l , Hemoglobin &gt; = 10 g / dl , Creatinine &lt; = 1.5 x upper normal , Total bilirubin &lt; = 1.25 x upper normal Transaminases ( AST ALT ) &lt; = 1.5 x upper normal , Alkaline phosphatase &lt; = 2.5 x upper normal . Cardiac Function : electrocardiogram ( ECG ) normal . Signed write consent procedure relate study . Men Non Menopausal Patients Patients hormone receptor negative : PR RE Contraindication antiestrogens ( risk thrombus arteria ) Tumor &lt; 3 cm operable Tumor inflammatory T4d ( PEV 2 3 ) . Extensive hepatic lesion ( &gt; 1 / 3 liver volume ) Uncontrolled cardiac disease angina , congestive heart failure , arrhythmia require medical treatment history myocardial infarction within 3 month . History cancer except skin cancer basal cell cancer situ cervix ( contralateral breast cancer systemic treatment admit ) . Chronic disease ( somatic psychiatric ) poor prognosis . Patients reason family , social , geographical psychological follow properly . Patients law protection</criteria>
	<gender>Female</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>locally advanced</keyword>
	<keyword>Menopausal patient</keyword>
	<keyword>aromasin</keyword>
	<keyword>tamoxifen</keyword>
	<keyword>efficacy</keyword>
</DOC>